Tag: Pharmaceutical industry news
Challenges at FDA & bluebird Bio Sale: What You Need to Know
This morning, Praxis Precision Medicine announced that an independent data monitoring committee recommended discontinuing a Phase 3 study involving its experimental treatment for essential tremors. The analysis indicated that the drug was unlikely to...
Sanders and Novo Nordisk CEO clash, Roche shifts focus, and more in Pharmalittle
Bernie Sanders, the U.S. Senate health committee chair, has taken a stand against major pharmacy benefit managers in an effort to lower the prices of Novo Nordisk's popular diabetes and obesity treatments, Ozempic and...
Alzheimer’s Drug Reversal & Bavarian Nordic’s Trump Views: Pharmalittle Update
As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see a college campus, or catching up on reading, there are...
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...
Pharmalittle: Updates on Charles River Monkey Shipments and VC Partners in China
Good day to you! The sun is shining, the birds are singing, and the Pharmalot campus is buzzing with activity. We're starting our day with a delicious cup of hot buttery rum coffee, sweetened...
Pharmalittle: RFK Jr. Vaccines Scandal & Kids’ Obesity Drug Prescriptions
Good morning and welcome to a new week of work. We hope you had a refreshing weekend because now it's time to get back to the usual routine of online meetings, phone calls, and...
New Title: Soft-Tissue Cancer Drug Approval and Zepbound Shortage Update: Pharmalittle News
Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a new treatment for a rare soft tissue cancer. This cutting-edge...
NIH Patent Freeze, Senate Hearing for FDA Chief: Pharmalittle Update
The National Institutes of Health (NIH) technology transfer offices have hit a roadblock, halting the filing of new patent applications and restricting the licensing of existing ones for the past five weeks, as reported...
FDA Oversight of Drug Shortages and AstraZeneca Threats: Pharmalittle News Update
As the week comes to a close, many are looking forward to weekend plans. Whether it's enjoying the outdoors, planning a holiday break, or connecting with loved ones, there are plenty of ways to...
U.K. Restricts Lilly’s Obesity Drug, Pharma Layoffs, and More: Pharmalittle Update
U.K. Restricts Lilly's Obesity Drug to Those in Greatest NeedIn a move to adapt to the rising demand for obesity treatment, the U.K. announced that it will be offering Eli Lilly's weight loss drug,...
Trump’s Drug Pricing Plan Update and Moderna’s Strategic Shift in Pharmalittle News
Well, hey there, folks! How's it going on this fine day? We're hanging in there, thank you very much, especially since we've hit the midpoint of the week. I mean, we've made it this...
Merck Drug Trial and Wegovy in China: Pharmalittle News Update
Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...